home / stock / nerv / nerv quote
$3.105 Last:
22.42% Change Percent:
$3.4 Open:
$2.5364 Previous Close:
$3.4 High:
$3.06 Low:
103,971 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2022-08-19 | 3.4 | 2.5364 | 3.4 | 3.06 | 103,971 |
2022-08-18 | 3.28 | 2.5364 | 3.67 | 3.2501 | 464,693 |
2022-08-17 | 3.15 | 2.5364 | 3.52 | 3.01 | 320,177 |
2022-08-16 | 3.1 | 2.5364 | 3.2 | 3.0001 | 125,214 |
2022-08-15 | 3.1 | 2.5364 | 3.33 | 3.06 | 285,716 |
2022-08-12 | 3.38 | 2.5364 | 3.6 | 3.1096 | 295,766 |
2022-08-11 | 3.4 | 2.5364 | 3.4 | 3.15 | 193,214 |
2022-08-10 | 3.74 | 2.5364 | 3.74 | 3.29 | 337,841 |
2022-08-09 | 4.38 | 2.5364 | 4.54 | 3.6 | 509,550 |
2022-08-08 | 4.78 | 2.5364 | 5.04 | 4.58 | 584,165 |
2022-08-05 | 3.99 | 2.5364 | 5.3729 | 3.82 | 2,041,491 |
2022-08-04 | 3.02 | 2.5364 | 7.15 | 2.85 | 37,629,023 |
2022-08-03 | 2.7653 | 2.5364 | 2.7653 | 2.62 | 28,775 |
2022-08-02 | 2.54 | 2.5364 | 2.79 | 2.54 | 35,817 |
2022-08-01 | 2.71 | 2.5364 | 2.71 | 2.5338 | 11,336 |
2022-07-29 | 2.6307 | 2.5364 | 2.71 | 2.63 | 5,192 |
2022-07-28 | 2.5364 | 2.5364 | 2.7086 | 2.53 | 11,398 |
2022-07-26 | 2.5155 | 2.5155 | 2.76 | 2.5155 | 15,569 |
2022-07-19 | 2.7595 | 2.86 | 2.9885 | 2.7595 | 15,829 |
2022-07-18 | 3.01 | 2.79 | 3.07 | 2.72 | 51,772 |
Minerva Neurosciences Inc Company Name:
NERV Stock Symbol:
NASDAQ Market:
Minerva Neurosciences Inc Website:
News, Short Squeeze, Breakout and More Instantly...
WALTHAM, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported key business updates and financial results for...
WALTHAM, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported key business updates and financial results for the ...
WALTHAM, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company developing therapies to treat central nervous system (CNS) disorders, announced today that it has received the official meeting minutes from the Type...